RAAS blockade, kidney disease, and expression of ACE2, the entry receptor for SARS-CoV-2, in kidney epithelial and endothelial cells

A Subramanian, KA Vernon, M Slyper, J Waldman… - bioRxiv, 2020 - biorxiv.org
Abstract SARS-CoV-2, the coronavirus that causes COVID-19, binds to angiotensin-
converting enzyme 2 (ACE2) on human cells. Beyond the lung, COVID-19 impacts diverse …

[PDF][PDF] RAAS blockade, kidney disease, and expression of ACE2, the entry receptor for SARS-CoV-2, in kidney epithelial and endothelial cells

A Subramanian, KA Vernon, M Slyper, J Waldman… - scholar.archive.org
Abstract SARS-CoV-2, the coronavirus that causes COVID-19, binds to angiotensin-
converting enzyme 2 (ACE2) on human cells. Beyond the lung, COVID-19 impacts diverse …

RAAS blockade, kidney disease, and expression of ACE2, the entry receptor for SARS-CoV-2, in kidney epithelial and endothelial cells

A Subramanian, K Vernon, M Slyper, J Waldman… - 2020 - pesquisa.bvsalud.org
ABSTRACT SARS-CoV-2, the coronavirus that causes COVID-19, binds to angiotensin-
converting enzyme 2 (ACE2) on human cells. Beyond the lung, COVID-19 impacts diverse …

[HTML][HTML] RAAS blockade, kidney disease, and expression of ACE2, the entry receptor for SARS-CoV-2, in kidney epithelial and endothelial cells

A Subramanian, KA Vernon, M Slyper, J Waldman… - 2020 - europepmc.org
Abstract SARS-CoV-2, the coronavirus that causes COVID-19, binds to angiotensin-
converting enzyme 2 (ACE2) on human cells. Beyond the lung, COVID-19 impacts diverse …

RAAS blockade, kidney disease, and expression of ACE2, the entry receptor for SARS-CoV-2, in kidney epithelial and endothelial cells

A Subramanian, K Vernon, M Slyper, J Waldman… - 2020 - pesquisa.bvsalud.org
RAAS blockade, kidney disease, and expression of ACE2, the entry receptor for SARS-CoV-2,
in kidney epithelial and endothelial cells | PREPRINT-BIORXIV loading 1 2 3 +A A -A 3.RAAS …